Literature DB >> 2122349

Effects of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts.

T Yamamoto1, J Varani, H K Soong, P R Lichter.   

Abstract

The authors investigated effects of two antimetabolites, 5-fluorouracil (5-FU) and mitomycin C (MMC), on proliferation and motility of cultured rabbit subconjunctival fibroblasts. Both drugs caused dose-dependent inhibition of fibroblast proliferation. These effects were reversible at lower doses (0.33 mg/l of 5-FU, 1.0 X 10(-3) mg/l of MMC) and at an early stage of treatment, but became irreversible at higher doses or after longer treatment times. The degree of growth inhibition reached a plateau after 7 days of treatment. Neither drug altered fibroblast migration in the agarose droplet motility assay or on the intra-cytoplasmic actin distribution by epifluorescent-light microscopy. These results indicate that 5-FU and MMC inhibit subconjunctival fibroblast function predominantly by their effect on cell proliferation rather than on cell motility. The clinical implications of these results may possibly support the use of a much lower total dose of subconjunctival antimetabolite than used in the 5-FU clinical trial.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122349     DOI: 10.1016/s0161-6420(90)32456-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  37 in total

1.  Decorin and suramin inhibit ocular fibroblast collagen production.

Authors:  H Mietz; P Chévez-Barrios; M W Lieberman; M Wendt; R Gross; S F Basinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

2.  Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias.

Authors:  E G Kemp; A N Harnett; S Chatterjee
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

3.  Immunolocalization of prolyl 4-hydroxylase in fibroblasts cultured from Tenon's capsule of humans.

Authors:  S Saika; A Ooshima; O Yamanaka; O Tonoe; Y Okada; Y Ohnishi; M Kimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

4.  Effect of fibrostatin C, an inhibitor of prolyl 4-hydroxylase, on collagen secretion by human Tenon's capsule fibroblasts in vitro.

Authors:  S Saika; A Ooshima; O Yamanaka; Y Okada; S Tanaka; Y Ohnishi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

5.  Mitomycin C, amniotic membrane transplantation and limbal conjunctival autograft for treating multirecurrent pterygia with symblepharon and motility restriction.

Authors:  Yu-Feng Yao; Wen-Ya Qiu; Yong-Ming Zhang; Scheffer C G Tseng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-12       Impact factor: 3.117

6.  Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.

Authors:  P T Finger; G Czechonska; S Liarikos
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

7.  Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium.

Authors:  R Rachmiel; H Leiba; S Levartovsky
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

8.  Topical Mitomycin-C enhances subbasal nerve regeneration and reduces erosion frequency in the debridement wounded mouse cornea.

Authors:  Sonali Pal-Ghosh; Ahdeah Pajoohesh-Ganji; Gauri Tadvalkar; Briana M Kyne; Xiaoqing Guo; James D Zieske; Mary Ann Stepp
Journal:  Exp Eye Res       Date:  2015-08-30       Impact factor: 3.467

9.  Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up.

Authors:  Jair Giampani; Adriana Silva Borges-Giampani; José Carlos Eudes Carani; Ernst Werner Oltrogge; Remo Susanna
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

10.  Effects of mitomycin C on the expression of chymase and mast cells in the conjunctival scar of a monkey trabeculectomy model.

Authors:  Kouhei Okada; Tetsuya Sugiyama; Shinji Takai; Denan Jin; Osamu Ishida; Masanori Fukmoto; Hidehiro Oku; Mizuo Miyazaki; Tsunehiko Ikeda
Journal:  Mol Vis       Date:  2009-10-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.